Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 2:34:67.
doi: 10.11604/pamj.2019.34.67.17993. eCollection 2019.

Pathology of Senegalese breast cancers

Megan Burke Fitzpatrick  1 , Mara Hester Rendi  2 , Nancy Barbara Kiviat  2 , Pape Toure  3 , Amadou Dem  3 , Papa Salif Sow  4 , Stephen Edward Hawes  2 , Qinghua Feng  2 , Kimberly Heller Allison  1
Affiliations

Pathology of Senegalese breast cancers

Megan Burke Fitzpatrick et al. Pan Afr Med J. .

Abstract

Introduction: Breast cancer is among the most common cancers among women in most of Africa. However, features of histologically confirmed breast cancers presenting in specific regional populations is limited. Our study describes the clinic-pathologic features of invasive breast cancer diagnosed in women undergoing biopsy for a clinically apparent mass in Senegal, West Africa.

Methods: A prospective cohort of 522 Senegalese women presenting consecutively to Dantec Hospital (University of Dakar Tumor Institute) with a breast mass were included in the study cohort. Demographic data was collected by survey and 197 (37.7%) core needle biopsy-confirmed invasive breast cancers available for review were subsequently centrally reviewed at the University of Washington in Seattle to further to characterize the pathologic features and to perform immunohistochemistry for ER/PR and HER2.

Results: Seventy six (76.1%) of the 522 Senegalese women presenting for biopsy of a clinically apparent breast mass were diagnosed with invasive breast cancer. The average age of a woman with invasive cancer was 46 years old, and most (83%) presented with Stage III or IV disease. The predominant histologic subtype among the 197 biopsy-confirmed cancers was invasive ductal carcinoma (98%), with few cases of invasive lobular carcinoma (2%). Cancers were classified into four clinically relevant treatment IHC groups by combined ER/PR status and HER2 status as follows: ER-/PR-, HER2- (n=92; 46.7%), ER-/PR-, HER2+ (n=20; 10.1%), ER+/PR+, HER2- (n=76; 38.6%) and ER+/PR+, HER2+ (n=9; 4.6%). Age at time of diagnosis was similar between these four subgroups although more HER2 positive cases were pre-menopausal (p=0.05). Stage of disease at presentation differed by IHC group (p=0.008), with HER2+ cancers significantly more likely to present with stage IV disease than other IHC groups, including ER-/PR-, HER2-. There were no significant differences between groups by age group, ethnicity, place of residence or birth, or parity.

Conclusion: Our analysis of breast cancer cases in Senegal shows a distribution of clinically relevant IHC groups like that seen in the few prior studies of breast cancer in West Africa, with higher frequencies of triple negative cancers than in most United States and European populations. Mean age at presentation, delayed presentation, and genetic/regional risk factors likely influence these differences. A better understanding of the frequencies of the pathologic features of breast cancers in the West African population may help guide future genetic studies as well as appropriate clinical management of breast cancer in these populations.

Keywords: Africa; Breast cancer; Senegal.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Distribution of ER, PR, and HER2 in non-triple negative breast cancers in Senegal
See this image and copyright information in PMC

References

    1. International Agency for research on cancer . World Health Organization. Global cancer observatory. Accessed 14 Sep 2017.
    1. Ly M, Valent A, Diallo G, Penault-Lorca F, Dumke K, Marty V, et al. Gene copy number variations in breast cancer of Sub-Saharan African women. The Breast. 2013 Jun;22(3):295–300. - PubMed
    1. Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD) Lancet Oncol. 2008 Aug;9(8):730–56. - PubMed
    1. Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer. J Clin Oncol. 2009 Sep 20;27(27):4515–21. - PMC - PubMed
    1. Dem A, Traoré B, Dieng MM, Diop PS, Ouajdi T, Lalami MT, et al. Gynaecological and breast cancers at the Dakar Cancer Institute. Sante. 2008 Jan-Mar;18(1):25–9. - PubMed

MeSH terms